Management of Raynaud’s Phenomenon

John D. Pauling

Molluscum Update (January 2024)

Elaine C. Siegfried

Systemic and Cutaneous Lupus Consideration

Masterclasses in Dermatology

J. Merola

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Practical Practice Pearls

Stephen Stone

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Cleveland Clinic Rheumatology

L. Calabrese, J. Gelfand, C. Oddis, J. Cush, A. Kavanaugh, R. Hajj-Ali

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Deroofing in HS

Hidradenitis Suppurativa Foundation

S. Daveluy

Skin Signs of Systemic Disease: Addressing Non-Responders and Caring…

Dermatology Education Foundation (DEF)

B. Glick

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Management of Necrotizing Fasciitis

Michael Booth

M. Booth

Hidradenitis Suppurativa: Starting Treatments

Hidradenitis Suppurativa Foundation

S. Daveluy

Dermatologic Toxicities to Immunotherapy

University of Louisville

A. Markova

Myths and Misconceptions ANCA Associated Vasculitis

RheumNow

M. Putman

Rheumatology Update for the Generalist in 2024

McMaster University Department of Medicine

R. Mirza

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama

AAD 2024 Insights: Practical Practice Pearls

AAD 2024

S. Stone

AAD 2024 Insights: Efficiently Managing HS in Any Clinic

Hidradenitis Suppurativa Foundation

S. Daveluy

How Does the Treatment of Behçet’s Disease Differ Based on Disease M…

Cleveland Clinic Rheumatology

G. Hatemi